Assessment of patients with alcoholic cirrhosis: Application of novel, modified Child-Pugh-Turcotte scores

Gastroenterologia Polska

Volumn 15, Issue 3, 2008, Pages 156-160

  Wunsch, Ewa ^a   Zawada, Iwona ^a   Mróz, Karolina ^a   Salamonik, Magdalena ^a   Milkiewicz, Piotr ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Alcoholic cirrhosis; Hepatorenal syndrome; Hyponatremia; Liver transplantation; Outcome assessment

Indexed keywords

CREATININE; SODIUM;

ADULT; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN TISSUE; HYPONATREMIA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SCORING SYSTEM;

EID: 48249092668     PISSN: 12329886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Everhart J.: Digestive Diseases in the United States: Epidemiology and Impact. NIH Publication, 1994, 94-1447.
2. Freeman R.B., Wiesner R.H., Roberts J.P., McDiarmid S., Dykstra D.M., Merion R.M.: Improving liver allocation: MELD and PELD. Am. J. Transplant., 2004, 4, 114-131.
3. Olthoff K.M., Brown R.S. Jr, Delmonico F.L., Freeman R.B., McDiarmid S.V., Merion R.M., Millis J.M., Roberts J.P., Snaked A., Wiesner R.H., Lucey M.R.: Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transpl., 2004, 10, A6-A22.
4. Wiesner R., Edwards E., Freeman R., Harper A., Kim R., Kamath P., Kremers W., Lake J., Howard T., Merion R.M., Wolfe R.A., Krom R.; the United Network For Organ Sharing: Liver Disease Severity Score Committee. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology, 2003, 124, 91-96.
5. Botta F., Giannini E., Romagnoli P., Fasoli A., Malfatti F., Chiarbonello B., Testa E., Risso D., Colla G., Testa R.: MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003, 52, 134-139.
6. Said A., Williams J., Holden J. Remington P., Gangnon R., Musat A., Lucey M.R.: Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J. Hepatol., 2004, 40, 897-903.
7. Dunn W., Jamil L.H., Brown L.S., Wiesner R.H., Kim W.R., Menon K.V., Malinchoc M., Kamath P.S., Shah V.: MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology, 2005, 41, 353-358.
8. Srikureja W., Kyulo N.L., Runyon B.A., Hu K.Q.: MELD score is a better prognostic model than Child-Pugh-Turcotte score or Discriminant Function score in patients with alcoholic hepatitis. J. Hepatol., 2005, 42, 700-706.
9. Kamath P.S., Wiesner R.H., Malinchoc M., Kremers W., Therneau T.M., Kosberg C.L., D'Amico G., Dickson E.R., Kim W.R.: A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33, 464-470.
10. Durand F., Valla D.: Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J. Hepatol., 2005, 42, S100-107.
11. Heuman D.M., Abou-Assi S.G., Habib A., Williams L.M., Stravitz R.T., Sanyal A.J., Fisher R.A., Mihas A.A.: Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatology, 2004, 40, 802-810.
12. Ferenci P., Lockwood A., Mullen K., Tarter R., Weissenborn K., Blei A.T.: Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. Hepatology, 2002, 35, 716-721.
13. Biggins S.W., Rodriguez H.J., Bacchetti P., Bass N.M., Roberts J.P., Terrault N.A.: Serum sodium predicts mortality in patients listed for liver transplantation. Hepatology, 2005, 41, 32-39.
14. Huo T.I., Wu J.C., Lee S.D.: MELD in liver transplantation: the da Vinci code for the Holy Grail? J. Hepatol., 2005, 42, 477-478.
15. Huo T.I., Wu J.C., Lin H.C., Lee F.Y., Hou M.C., Huang Y.H., Lee P.C., Chang F.Y., Lee S.D.: Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy. Liver Transpl., 2004, 10, 1507-1513.
16. Huo T.I., Wang Y.W., Yang Y.Y., Lin H.C., Lee P.C., Hou M.C., Lee F.Y., Lee S.D.: Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int., 2007, 27, 498-506.
17. Huo T.I., Lin H.C., Wu J.C., Lee F.Y., Hou M.C., Lee P.C., Chang F.Y., Lee S.D.: Proposal of a modified Child-Pugh-Turcotte scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl., 2006, 12, 65-71.
18. Arroyo V., Guevara M., Gines P.: Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology, 2002, 122, 1658-1676.
19. Gines A., Escorsell A., Gines P., Saló J., Jiménez W., Inglada L., Navasa M., Clŕria J., Rimola A., Arroyo V.: Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology, 1993, 105, 229-236.
20. Alessandria C., Ozdogan O., Guevara M., Restuccia T., Jimenez W., Arroyo V., Rodes J., Gines P.: MELD score and clinical type predict prognosis in hepatorenal syndrome: Relevance to liver transplantation. Hepatology, 2005, 41, 1282-1289.
21. Ruf A.E., Kremers W.K., Chavez L.L., Descalzi V.I., Podesta L.G., Villamil F.G.: Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl., 2005, 11, 336-343.
22. Bosch J., Arroyo V., Betriu A., Mas A., Carrilho F., Rivera F., Navarro-Lopez F., Rodes J.: Hepatic hemodynamics and the rennin-angiotensin- aldosterone system in cirrhosis. Gastroenterology, 1980, 78, 92-99.